The traditional Chinese medicine rehabilitation for post-stroke dysphagia impairment will be intervened, which can promote the recovery of dysphagia function of stroke patients, reduce the disability rate and improve the quality of life.

This study will collect inpatients from April 2020 to December 2022 who from the third affiliated hospital of Zhejiang university of traditional Chinese medicine, Jiaxing hospital of traditional Chinese medicine, Hangzhou hospital of traditional Chinese medicine.this study sets strict time window (stroke recovery, 30-180 days), use multi-center, large sample, randomized controlled study method and the objective recognition rehabilitation evaluation criteria and efficacy evaluation system to evaluate the clinical effect and analysis of health economics.

Inclusion Criteria:

• Dysphagia

  • Meet the diagnostic criteria of stroke in traditional Chinese medicine;
  • Meet the diagnostic criteria of ischemic stroke in western medicine;
  • meet the diagnostic criteria of pseudobulbar palsy;
  • Age is 18-85, gender not limited;
  • The course of disease is 30 to 180 days;
  • Water test level 3 and level 3 above;
  • Meet the requirements for indications of acupuncture and moxibustion techniques; Volunteer to participate in this project, the patient has no serious complications, can accept acupuncture treatment and good compliance;
  • Sign informed consent
  • MOCA（Montreal Cognitive Assessment） score above 15.

Exclusion Criteria:

• Dysphagia

  • Patients with true bulbar palsy caused by brainstem encephalitis, motor neurone disease, pontine tumor, multiple sclerosis, myasthenia gravis, medulla bulbar cavity;
  • Cerebral hemorrhage caused by cerebrovascular malformation, trauma, aneurysm and other causes;
  • Pregnant or lactating women;
  • Patients with severe primary chronic diseases, severe dementia and cognitive impairment, serious language understanding disorders, and mental illness, including heart, liver, kidney and other viscera, as well as the endocrine system and hematopoietic system;
  • Suffered from a variety of bleeding tendency diseases;
  • The patient to swallow contrast drug allergy;
  • Patients who do not meet the inclusion criteria, do not have poor treatment compliance as prescribed, cannot judge the efficacy or incomplete data affect the judgment of efficacy and are not suitable for clinical observation;